Skip to main content
SpringerLink
Log in

The US FDA should consider increasing the number of patients required for new drug application clinical trials

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

The US FDA should consider increasing the number of patients required for new drug application clinical trials. React. Wkly. 752, 2 (1999). https://doi.org/10.2165/00128415-199907520-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-199907520-00004

Keywords

Search

Navigation